Attached files

file filename
10-K - ANNUAL REPORT - cbdMD, Inc.ycbd_10k.htm
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - cbdMD, Inc.ycbd_ex321.htm
EX-31.3 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - cbdMD, Inc.ycbd_ex313.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - cbdMD, Inc.ycbd_ex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - cbdMD, Inc.ycbd_ex311.htm
  Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm
 
 
We hereby consent to the incorporation by reference of our report dated December 22, 2020, relating to the audits of the consolidated balance sheets of cbdMD, Inc. and subsidiaries (the “Company”) as of September 30, 2020 and 2019 and the related consolidated statements of operations, comprehensive income (loss), shareholders’ equity and cash flows for the years then ended, included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2020, which is filed with the United States Securities and Exchange Commission (the “SEC”) in the Company’s (i) Registration Statement on Form S-1, as amended (SEC File No. 333-227529), as declared effective by the SEC on September 28, 2018; (ii) Registration Statement on Form S-8 (SEC File No. 333-227746) as filed with the SEC on October 9, 2018; (iii) Registration Statement on Form S-3, as amended (SEC File No. 333-228773), as declared effective by the SEC on April 9, 2019; and (iv) Registration Statement on Form S-8 (SEC File No. 333-223291) as filed with the SEC on August 15, 2019.
 
 
/s/ Cherry Bekaert LLP
 
Charlotte, North Carolina
December 22, 2020